Variant report
Variant | esv2573192 |
---|---|
Chromosome Location | chr15:45134952-45144769 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:82)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BCL11A | chr15:45137220-45137412 | GM12878 | blood: | n/a | n/a |
2 | CEBPB | chr15:45144416-45144724 | HepG2 | liver: | n/a | chr15:45144570-45144581 |
3 | CEBPB | chr15:45144517-45144702 | Hela-S3 | cervix: | n/a | chr15:45144570-45144581 |
4 | CEBPB | chr15:45144483-45144746 | K562 | blood: | n/a | chr15:45144570-45144581 |
5 | CTCF | chr15:45141120-45141270 | HCPEpiC | choroid plexus: | n/a | n/a |
6 | CTCF | chr15:45138479-45138666 | K562 | blood: | n/a | chr15:45138563-45138584 |
7 | CTCF | chr15:45141235-45141321 | Gliobla | brain: | n/a | n/a |
8 | CTCF | chr15:45141195-45141335 | NHEK | skin: | n/a | n/a |
9 | CTCF | chr15:45141212-45141334 | LNCaP | prostate: | n/a | n/a |
10 | CTCF | chr15:45141160-45141310 | HPAF | blood vessel: | n/a | n/a |
11 | CTCF | chr15:45141260-45141410 | NHEK | skin: | n/a | n/a |
12 | CTCF | chr15:45138545-45138554 | GM10266 | blood: | n/a | n/a |
13 | CTCF | chr15:45141131-45141356 | A549 | lung: | n/a | n/a |
14 | CTCF | chr15:45138576-45138589 | HUVEC | blood vessel: | n/a | n/a |
15 | CTCF | chr15:45141105-45141352 | K562 | blood: | n/a | n/a |
16 | CTCF | chr15:45141172-45141373 | K562 | blood: | n/a | n/a |
17 | CTCF | chr15:45138541-45138598 | GM13976 | blood: | n/a | chr15:45138563-45138584 |
18 | CTCF | chr15:45141160-45141310 | Hela-S3 | cervix: | n/a | n/a |
19 | CTCF | chr15:45141239-45141244 | Kidney_OC | kidney: | n/a | n/a |
20 | CTCF | chr15:45141180-45141330 | HCM | heart: | n/a | n/a |
21 | CTCF | chr15:45141076-45141340 | K562 | blood: | n/a | n/a |
22 | CTCF | chr15:45141103-45141426 | K562 | blood: | n/a | n/a |
23 | CTCF | chr15:45141229-45141238 | Kidney_OC | kidney: | n/a | n/a |
24 | CTCF | chr15:45141160-45141310 | HepG2 | liver: | n/a | n/a |
25 | CTCF | chr15:45141197-45141353 | MCF-7 | breast: | n/a | n/a |
26 | CTCF | chr15:45141160-45141310 | HBMEC | blood vessel: | n/a | n/a |
27 | CTCF | chr15:45138505-45138644 | Pancreas_OC | pancreas: | n/a | chr15:45138563-45138584 |
28 | CTCF | chr15:45138526-45138614 | Hela-S3 | cervix: | n/a | chr15:45138563-45138584 |
29 | CTCF | chr15:45141150-45141359 | HepG2 | liver: | n/a | n/a |
30 | CTCF | chr15:45141197-45141342 | LNCaP | prostate: | n/a | n/a |
31 | CTCF | chr15:45141228-45141322 | Fibrobl | skin: | n/a | n/a |
32 | CTCF | chr15:45138539-45138575 | HUVEC | blood vessel: | n/a | n/a |
33 | CTCF | chr15:45141140-45141290 | HMEC | breast: | n/a | n/a |
34 | CTCF | chr15:45144640-45144790 | HPF | lung: | n/a | n/a |
35 | CTCF | chr15:45138426-45138674 | K562 | blood: | n/a | chr15:45138563-45138584 |
36 | CTCF | chr15:45141160-45141310 | WERI-Rb-1 | eye: | n/a | n/a |
37 | CTCF | chr15:45141160-45141310 | AoAF | blood vessel: | n/a | n/a |
38 | CTCF | chr15:45141192-45141337 | HepG2 | liver: | n/a | n/a |
39 | CTCF | chr15:45141220-45141370 | HRPEpiC | eye: | n/a | n/a |
40 | CTCF | chr15:45141120-45141270 | K562 | blood: | n/a | n/a |
41 | CTCF | chr15:45141160-45141310 | SAEC | small airway: | n/a | n/a |
42 | CTCF | chr15:45141166-45141361 | MCF-7 | breast: | n/a | n/a |
43 | CTCF | chr15:45141160-45141310 | GM12873 | blood: | n/a | n/a |
44 | CTCF | chr15:45141220-45141370 | HPAF | blood vessel: | n/a | n/a |
45 | CTCF | chr15:45138522-45138630 | MCF-7 | breast: | n/a | chr15:45138563-45138584 |
46 | CTCF | chr15:45138461-45138641 | HepG2 | liver: | n/a | chr15:45138563-45138584 |
47 | CTCF | chr15:45141187-45141375 | HUVEC | blood vessel: | n/a | n/a |
48 | CTCF | chr15:45141080-45141230 | HMEC | breast: | n/a | n/a |
49 | CTCF | chr15:45138565-45138682 | HepG2 | liver: | n/a | n/a |
50 | CTCF | chr15:45141199-45141353 | Hela-S3 | cervix: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000238845 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs553301175 | chr15:45134964-45134965 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs74009449 | chr15:45134981-45134982 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs545036447 | chr15:45134995-45134996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs17592201 | chr15:45135017-45135018 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
5 | rs530932875 | chr15:45135088-45135089 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs544660481 | chr15:45135089-45135090 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs560927855 | chr15:45135114-45135115 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs529960757 | chr15:45135128-45135129 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs546807338 | chr15:45135133-45135134 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs371118636 | chr15:45135166-45135167 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs566805948 | chr15:45135168-45135169 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs532424024 | chr15:45135189-45135190 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs551905368 | chr15:45135235-45135236 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs568799620 | chr15:45135258-45135259 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs145072818 | chr15:45135259-45135260 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs188479553 | chr15:45135263-45135264 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs567813649 | chr15:45135337-45135338 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs2462033 | chr15:45135350-45135351 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs16975717 | chr15:45135358-45135359 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
20 | rs138854575 | chr15:45135362-45135363 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs16975720 | chr15:45135369-45135370 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs545656942 | chr15:45135373-45135374 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs146298734 | chr15:45135407-45135408 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs575546504 | chr15:45135439-45135440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs544275399 | chr15:45135519-45135520 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs148075516 | chr15:45135520-45135521 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs370343893 | chr15:45135542-45135543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs540458166 | chr15:45135561-45135562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs374841506 | chr15:45135624-45135625 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs16977224 | chr15:45135704-45135705 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs2462031 | chr15:45135717-45135718 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs532461607 | chr15:45135733-45135734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs552405722 | chr15:45135786-45135787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs113733844 | chr15:45135796-45135797 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs202223005 | chr15:45135829-45135830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs562350607 | chr15:45135849-45135850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs531384950 | chr15:45135851-45135852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs547869840 | chr15:45135880-45135881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs567852160 | chr15:45135911-45135912 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs2948909 | chr15:45135930-45135931 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs546812777 | chr15:45135945-45135946 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs566691380 | chr15:45135947-45135948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs192192306 | chr15:45135967-45135968 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs371743961 | chr15:45135972-45135973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs150684821 | chr15:45135976-45135977 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs575836911 | chr15:45136041-45136042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs139920257 | chr15:45136085-45136086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs554980969 | chr15:45136117-45136118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs182418959 | chr15:45136138-45136139 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs572853981 | chr15:45136140-45136141 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Schizophrenia | 19415332 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
cataract | 16735990 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 21979893 | CNVD |
spastic paraplegia with thinning of corpus callosum | 19105190 | CNVD |
Schizophrenia | 21324950 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Disease | 21824424 | CNVD |
Melanoma | 18172304 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Gastric cancer | 17167181 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Intellectual disability | 22102821 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21785460 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Cancer | 21129771 | CNVD |
Papillary thyroid carcinoma | 22161024 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 21045282 | CNVD |
Breast cancer | 22032731 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Cancer | 16751803 | CNVD |
Melanoma | 17363583 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Marfan syndrome | 17492313 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Non-syndromic sensorineural hearing loss | 19212409 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr15:45132200-45135000 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
2 | chr15:45134400-45141000 | Weak transcription | HepG2 | liver |
3 | chr15:45135000-45135400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
4 | chr15:45137400-45138200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
5 | chr15:45137600-45137800 | Enhancers | Pancreas | Pancrea |
6 | chr15:45137800-45145200 | Weak transcription | Pancreas | Pancrea |
7 | chr15:45138000-45138200 | Enhancers | Duodenum Mucosa | Duodenum |
8 | chr15:45141000-45142000 | Enhancers | Liver | Liver |
9 | chr15:45141000-45142200 | Enhancers | HepG2 | liver |
10 | chr15:45141200-45145600 | Enhancers | HUVEC | blood vessel |
11 | chr15:45141800-45142200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
12 | chr15:45141800-45142200 | Enhancers | Lung | lung |
13 | chr15:45142000-45144400 | Weak transcription | Liver | Liver |
14 | chr15:45142200-45143800 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
15 | chr15:45142200-45143800 | Weak transcription | HepG2 | liver |
16 | chr15:45143800-45145000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
17 | chr15:45143800-45145400 | Enhancers | HepG2 | liver |
18 | chr15:45144400-45147200 | Enhancers | Liver | Liver |
19 | chr15:45144600-45145400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
20 | chr15:45144600-45146000 | Enhancers | K562 | blood |